Zobrazeno 1 - 4
of 4
pro vyhledávání: '"MESH: Enzyme Replacement Therapy"'
Autor:
Constantinos Papadopoulos, David Orlikowski, Hélène Prigent, Arnaud Lacour, Céline Tard, Alain Furby, Julien Praline, Guilhem Solé, Jean-Yves Hogrel, Marie De Antonio, Claudio Semplicini, Joelle Deibener-Kaminsky, Pierre Kaminsky, Bruno Eymard, Nadjib Taouagh, Barbara Perniconi, Dalil Hamroun, Pascal Laforêt, G. Bassez, A.-L. Bedat-Millet, A. Behin, B. Eymard, S. Leonard-Louis, T. Stojkovic, A. Canal, V. Decostre, F. Bouhour, F. Boyer, C. Caillaud, Y. Castaing, F. Chapon, P. Cintas, I. Durieu, A. Echaniz-Laguna, L. Feasson, X. Ferrer, R. Froissart, M. Piraud, D. Germain, K. Benistan, N. Guffon-Fouilhoux, H. Journel, P. Labauge, A. Levy, A. Magot, Y. Péréon, M.-C. Minot-Myhié, A. Nadaj-Pakleza, C. Nathier, N. Pellegrini, P. Petiot, F. Lofaso, A. Dutry, D. Renard, S. Sacconi, C. Desnuelle, E. Salort-Campana, J. Pouget, V. Tiffreau, D. Vincent, F. Zagnoli
Publikováno v:
Molecular Genetics and Metabolism
Molecular Genetics and Metabolism, 2017, Molecular genetics and metabolism, 122 (1-2), pp.80-85. ⟨10.1016/j.ymgme.2017.06.007⟩
Molecular Genetics and Metabolism, Elsevier, 2017, Molecular genetics and metabolism, 122 (1-2), pp.80-85. ⟨10.1016/j.ymgme.2017.06.007⟩
Molecular Genetics and Metabolism, 2017, Molecular genetics and metabolism, 122 (1-2), pp.80-85. ⟨10.1016/j.ymgme.2017.06.007⟩
Molecular Genetics and Metabolism, Elsevier, 2017, Molecular genetics and metabolism, 122 (1-2), pp.80-85. ⟨10.1016/j.ymgme.2017.06.007⟩
Background The efficacy of enzyme replacement therapy (ERT) in patients at an advanced stage of Pompe disease has only been addressed in a few studies. Our objective was to assess the long term effects of ERT in a cohort of patients with severe Pompe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eca040ef3e520953509b66aeb672813
https://hal.univ-lille.fr/hal-02369159
https://hal.univ-lille.fr/hal-02369159
Autor:
Laure-Hélène Noël, Vassili Valayannopoulos, Pierre Ronco, Niaudet P, Olivia Boyer, Patrice Callard, Pascale de Lonlay, Hanna Debiec, Hélène Sarda
Publikováno v:
Journal of the American Society of Nephrology
Journal of the American Society of Nephrology, 2014, 25 (4), pp.675-680. ⟨10.1681/ASN.2013030290⟩
Journal of the American Society of Nephrology; Vol 25
Journal of the American Society of Nephrology, American Society of Nephrology, 2014, 25 (4), pp.675-80. ⟨10.1681/ASN.2013030290⟩
Journal of the American Society of Nephrology, American Society of Nephrology, 2014, 25 (4), pp.675-680. ⟨10.1681/ASN.2013030290⟩
Journal of the American Society of Nephrology, American Society of Nephrology, 2014, 25 (4), pp.675-80. 〈10.1681/ASN.2013030290〉
Journal of the American Society of Nephrology, 2014, 25 (4), pp.675-80. ⟨10.1681/ASN.2013030290⟩
Journal of the American Society of Nephrology, 2014, 25 (4), pp.675-680. ⟨10.1681/ASN.2013030290⟩
Journal of the American Society of Nephrology; Vol 25
Journal of the American Society of Nephrology, American Society of Nephrology, 2014, 25 (4), pp.675-80. ⟨10.1681/ASN.2013030290⟩
Journal of the American Society of Nephrology, American Society of Nephrology, 2014, 25 (4), pp.675-680. ⟨10.1681/ASN.2013030290⟩
Journal of the American Society of Nephrology, American Society of Nephrology, 2014, 25 (4), pp.675-80. 〈10.1681/ASN.2013030290〉
Journal of the American Society of Nephrology, 2014, 25 (4), pp.675-80. ⟨10.1681/ASN.2013030290⟩
International audience; Nephrotic syndrome was reported in a highly-sensitized patient receiving enzyme replacement therapy (ERT) for Pompe disease, but the prevalence of ERT-induced renal complications and mechanisms to facilitate readministration o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bef8a952af058a920f7ff0d2f53f39d
https://www.hal.inserm.fr/inserm-02191546
https://www.hal.inserm.fr/inserm-02191546
Autor:
Leonardo Salviati, Claude Desnuelle
Publikováno v:
Current Opinion in Neurology
Current Opinion in Neurology, Lippincott, Williams & Wilkins, 2011, 24 (5), pp.443-8. ⟨10.1097/WCO.0b013e32834a1e00⟩
Current Opinion in Neurology, Lippincott, Williams & Wilkins, 2011, 24 (5), pp.443-8. ⟨10.1097/WCO.0b013e32834a1e00⟩
International audience; PURPOSE OF REVIEW: The first reports published in 2010 on enzyme replacement therapy in late-onset Pompe disease (LOPD) allow us now to stand back and adapt the strategies. In the meantime, substantial progress has been made i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22aaf055b101ec3c1d9b7d484d95f6cc
https://hal.archives-ouvertes.fr/hal-00756605
https://hal.archives-ouvertes.fr/hal-00756605
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology, Wiley, 2010, 24 (6), pp.737-8. ⟨10.1111/j.1468-3083.2009.03455.x⟩
Journal of the European Academy of Dermatology and Venereology, Wiley, 2010, 24 (6), pp.737-8. ⟨10.1111/j.1468-3083.2009.03455.x⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8f1250c0bae4f430025d17f2282fd1a1
https://hal-unilim.archives-ouvertes.fr/hal-00595306
https://hal-unilim.archives-ouvertes.fr/hal-00595306